| Literature DB >> 26131963 |
Viviana Meraviglia1, Alessandra Zanon1, Alexandros A Lavdas1, Christine Schwienbacher1, Rosamaria Silipigni2, Marina Di Segni2, Huei-Sheng Vincent Chen3, Peter P Pramstaller1, Andrew A Hicks1, Alessandra Rossini4.
Abstract
Somatic cells can be reprogrammed into induced pluripotent stem cells (iPSCs) by forcing the expression of four transcription factors (Oct-4, Sox-2, Klf-4, and c-Myc), typically expressed by human embryonic stem cells (hESCs). Due to their similarity with hESCs, iPSCs have become an important tool for potential patient-specific regenerative medicine, avoiding ethical issues associated with hESCs. In order to obtain cells suitable for clinical application, transgene-free iPSCs need to be generated to avoid transgene reactivation, altered gene expression and misguided differentiation. Moreover, a highly efficient and inexpensive reprogramming method is necessary to derive sufficient iPSCs for therapeutic purposes. Given this need, an efficient non-integrating episomal plasmid approach is the preferable choice for iPSC derivation. Currently the most common cell type used for reprogramming purposes are fibroblasts, the isolation of which requires tissue biopsy, an invasive surgical procedure for the patient. Therefore, human peripheral blood represents the most accessible and least invasive tissue for iPSC generation. In this study, a cost-effective and viral-free protocol using non-integrating episomal plasmids is reported for the generation of iPSCs from human peripheral blood mononuclear cells (PBMNCs) obtained from frozen buffy coats after whole blood centrifugation and without density gradient separation.Entities:
Mesh:
Year: 2015 PMID: 26131963 PMCID: PMC4545018 DOI: 10.3791/52885
Source DB: PubMed Journal: J Vis Exp ISSN: 1940-087X Impact factor: 1.355